P

Inventor

CAVAZZA CLAUDIO

IT111 patents
⚠️ This page may combine multiple inventors who share the name “CAVAZZA CLAUDIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIGMA TAU IND FARMACEUTI

26 patents
US6063820AMay 16, 2000

Medical food for diabetics

SIGMA TAU IND FARMACEUTI120 citations98
US3968872AJul 13, 1976

Device, provided with a puncher and a dripper, for the hermetic sealing of containers

SIGMA TAU IND FARMACEUTI160 citations97
US6372940B1Apr 16, 2002

Process for the preparation of non-hygroscopic salts of L(−)-carnitine

SIGMA TAU IND FARMACEUTI78 citations96
US5747536AMay 5, 1998

Pharmaceutical composition comprising L-carnitine or derivative thereof and trihydroxy or tetrahydroxystilbene

SIGMA TAU IND FARMACEUTI54 citations96
US5145871ASep 8, 1992

Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment

SIGMA TAU IND FARMACEUTI48 citations96
US4602039AJul 22, 1986

Salts of-carnitine and alkanoyl L-carnitines and process for preparing same

SIGMA TAU IND FARMACEUTI82 citations96
US5753703AMay 19, 1998

Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders

SIGMA TAU IND FARMACEUTI55 citations95
US6914076B2Jul 5, 2005

Treating chronic uremic patients undergoing periodical dialysis

SIGMA TAU IND FARMACEUTI19 citations93
US6696493B2Feb 24, 2004

Treating chronic uremic patients undergoing periodic dialysis

SIGMA TAU IND FARMACEUTI32 citations93
US6429230B1Aug 6, 2002

Treating chronic uremic patients undergoing periodical dialysis

SIGMA TAU IND FARMACEUTI33 citations93
US6328998B1Dec 11, 2001

Composition comprising L-carnitine or an alkanoyl L-carnitine and long-chain alkanols

SIGMA TAU IND FARMACEUTI19 citations93
US5432199AJul 11, 1995

Use of acetyl D-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment

SIGMA TAU IND FARMACEUTI35 citations93
US5037851AAug 6, 1991

Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment

SIGMA TAU IND FARMACEUTI26 citations93
US4244467AJan 13, 1981

Device for the extemporaneous preparation of a solution under sterile conditions

SIGMA TAU IND FARMACEUTI42 citations93
US4130116ADec 19, 1978

Pocket inhalator

SIGMA TAU IND FARMACEUTI38 citations93
US6610699B2Aug 26, 2003

Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity

SIGMA TAU IND FARMACEUTI17 citations84
US6335369B1Jan 1, 2002

Treating chronic uremic patients undergoing periodical dialysis

SIGMA TAU IND FARMACEUTI16 citations84
US5227518AJul 13, 1993

L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis

SIGMA TAU IND FARMACEUTI19 citations82
US5192805AMar 9, 1993

Use of acetyl l-carnitine in the therapeutic treatment of coma

SIGMA TAU IND FARMACEUTI18 citations82
US4415589ANov 15, 1983

Use of carnitine and of lower acyl-carnitines in the therapeutic treatment of the pathology of the veins

SIGMA TAU IND FARMACEUTI25 citations82
US4371618AFeb 1, 1983

Process for enzymatically producing L-carnitine

SIGMA TAU IND FARMACEUTI26 citations82
US4346820AAug 31, 1982

Apparatus for mixing and dispersing two substances under sterile conditions

SIGMA TAU IND FARMACEUTI27 citations82
US6696492B1Feb 24, 2004

Use of L carnitine and its alkanoyl dervatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy

SIGMA TAU IND FARMACEUTI16 citations77
US6932999B2Aug 23, 2005

Food supplemented with a carnitine, suitable for stimulating the biosynthesis of polyunsaturated fatty acids from the saturated fatty acids contained in the food

SIGMA TAU IND FARMACEUTI5 citations74
US6780851B1Aug 24, 2004

Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan

SIGMA TAU IND FARMACEUTI8 citations74
US6761898B1Jul 13, 2004

Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders

SIGMA TAU IND FARMACEUTI6 citations74

CAVAZZA CLAUDIO

13 patents
US4338931AJul 13, 1982

Device for the quick inhalation of drugs in powder form by humans suffering from asthma

CAVAZZA CLAUDIO294 citations99
US4343816AAug 10, 1982

Pharmaceutical composition comprising an acyl-carnitine, for treating peripheral vascular diseases

CAVAZZA CLAUDIO62 citations96
US4195731AApr 1, 1980

Device for containing a substance to be mixed with another substance in a vial

CAVAZZA CLAUDIO97 citations96
US4346107AAug 24, 1982

Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

CAVAZZA CLAUDIO76 citations95
US4439438AMar 27, 1984

Esters of acyl-carnitines, process for preparing same and pharmaceutical compositions containing such esters

CAVAZZA CLAUDIO32 citations93
US4255449AMar 10, 1981

Method of treating abnormal lipoprote in ratios

CAVAZZA CLAUDIO44 citations93
US4194006AMar 18, 1980

Therapeutic application of acetyl-d,l-carnitine and other acyl derivatives of d,l-carnitine

CAVAZZA CLAUDIO32 citations93
US4443475AApr 17, 1984

Amides of acyl-carnitines, process for preparing same and pharmaceutical compositions containing such amides

CAVAZZA CLAUDIO20 citations82
US4362719ADec 7, 1982

Therapeutic method and compositions for the treatment of juvenile diabetes mellitus

CAVAZZA CLAUDIO24 citations82
US4320145AMar 16, 1982

Pharmaceutical composition for parenteral nutrition comprising L-carnitine or acyl L-carnitines

CAVAZZA CLAUDIO28 citations82
US4272549AJun 9, 1981

Therapeutical method for the treatment of chronic uraemic patients undergoing periodical haemodialysis and liquid composition for dialysis for use in such a method

CAVAZZA CLAUDIO17 citations82
US4268524AMay 19, 1981

Method of treating abnormal lipoprotein ratios with acylcarnitine

CAVAZZA CLAUDIO22 citations82
US4237167ADec 2, 1980

Acyl-carnitines in a therapeutical method for treating chronic uraemic patients undergoing regular dialysis and liquid composition for use therein

CAVAZZA CLAUDIO24 citations82

SIGMA TAU HEALTHSCIENCE SPA

10 patents
US6365622B1Apr 2, 2002

Antioxidant composition comprising acetyl L-carnitine and α-lipoic acid

SIGMA TAU HEALTHSCIENCE SPA63 citations96
US6653349B1Nov 25, 2003

Composition for the prevention and treatment of kidney dysfunctions and diseases

SIGMA TAU HEALTHSCIENCE SPA18 citations93
US6602512B1Aug 5, 2003

Composition for the prevention of muscle fatique and skeletal muscle adaptation of strenuous exercise

SIGMA TAU HEALTHSCIENCE SPA29 citations93
US6515020B1Feb 4, 2003

Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders

SIGMA TAU HEALTHSCIENCE SPA22 citations93
US6346282B1Feb 12, 2002

Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-L-carnitine and hypericin

SIGMA TAU HEALTHSCIENCE SPA18 citations93
US6335038B1Jan 1, 2002

Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome

SIGMA TAU HEALTHSCIENCE SPA39 citations93
US6335021B1Jan 1, 2002

Composition for controlling mood disorders in healthy individuals

SIGMA TAU HEALTHSCIENCE SPA44 citations93
US6245378B1Jun 12, 2001

Nutritional supplement for facilitating skeletal muscle adaptation to strenuous exercise and counteracting defatigation in asthenic individuals

SIGMA TAU HEALTHSCIENCE SPA39 citations93
US6217898B1Apr 17, 2001

Pharmaceutical composition comprising carnitine or alkanoyl L-carnitine, for the prevention and treatment of diseases brought about by lipid metabolism disorders

SIGMA TAU HEALTHSCIENCE SPA40 citations93
US6306392B1Oct 23, 2001

Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects

SIGMA TAU HEALTHSCIENCE SPA17 citations84

AVANTGARDE SPA

1 patent

Showing the top 50 of 111 patents by PatentIndex Score.